You have accessJournal of UrologyBPH/Male Voiding Dysfunction/Infection/Misc. Imaging (V11)1 May 2024V11-12 STAR-P—SUPRAPUBIC TRANSVESICAL ADENOMA RESECTION OF THE PROSTATE—ORIGINAL TECHNIQUE FOR SURGICAL TREATMENT OF BPH: A NOVEL URETHRA-SPARING STRATEGY FOR ANY PROSTATIC VOLUME Bruno Bucca, Luca Matteo Gobbi, Vincenzo Asero, Carlo Maria Scornajenghi, Federico Alviani, Leslie Claire Licari, Eugenio Bologna, and Christian Gozzi Bruno BuccaBruno Bucca , Luca Matteo GobbiLuca Matteo Gobbi , Vincenzo AseroVincenzo Asero , Carlo Maria ScornajenghiCarlo Maria Scornajenghi , Federico AlvianiFederico Alviani , Leslie Claire LicariLeslie Claire Licari , Eugenio BolognaEugenio Bologna , and Christian GozziChristian Gozzi View All Author Informationhttps://doi.org/10.1097/01.JU.0001009368.07681.43.12AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Many minimally invasive treatments have been developed to treat benign prostatic hyperplasia (BPH) through a transurethral approach, with a non-negligible risk of complications such as urethral strictures or external sphincter damage. The aim of this study is to describe our surgical technique of Suprapubic Transvesical Adenoma Resection of theProstate (STAR-P) for BPH and to assess its safety, feasibility and outcomes. METHODS: A retrospective analysis of prospective collected data of 26 consecutive patients who underwent STAR-P for BPH was performed. All the procedures were performed in a single private hospital by one surgeon from 2020 to 2021. An innovative resectoscope was designed by C. Gozzi and subsequently produced by Tontarra® with a 42.06 Fr external sheath capable of allowing the use of loops of three different sizes. The instrument is inserted into the bladder through a suprapubic access ensuring greater freedom of movement without compromising the external sphincter. After the resection, a urinary catheter is left in place. Clinical data were collected in a dedicated database. Intraoperative variables, postoperative complications, and functional outcomes of STAR-P were assessed. A descriptive statistical analysis was performed. RESULTS: No intra- or post-operative complications were 49 observed. Median surgery time was 90 minutes. All patients showed an improvement in voiding quality with a remarkable median IPSS post-surgery (2.00). All complications related to the transurethral approach were avoided. CONCLUSIONS: The STAR-P is a safe and effective urethra-sparing procedure. This technique should be discussed with the patient as one of the possible alternatives for treating BPH. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e915 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Bruno Bucca More articles by this author Luca Matteo Gobbi More articles by this author Vincenzo Asero More articles by this author Carlo Maria Scornajenghi More articles by this author Federico Alviani More articles by this author Leslie Claire Licari More articles by this author Eugenio Bologna More articles by this author Christian Gozzi More articles by this author Expand All Advertisement PDF downloadLoading ...
